首站-论文投稿智能助手
典型文献
Parthenolide reveals an allosteric mode to inhibit the delSGylation activity of SARS-CoV-2 papain-like protease
文献摘要:
The coronavirus papain-like protease(PLpro)of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is responsible for viral polypeptide cleavage and the delSGylation of interferon-stimulated gene 15(ISG15),which enable it to participate in virus replication and host innate immune pathways.Therefore,PLpro is considered an attractive antiviral drug target.Here,we show that parthenolide,a germacrane sesquiterpene lactone,has SARS-CoV-2 PLpro inhibitory activity.Parthenolide covalently binds to Cys-191 or Cys-194 of the PLpro protein,but not the Cys-111 at the PLpro catalytic site.Mutation of Cys-191 or Cys-194 reduces the activity of PLpro.Molecular docking studies show that parthenolide may also form hydrogen bonds with Lys-192,Thr-193,and Gln-231.Furthermore,parthenolide inhibits the delSGylation but not the deubiquitinating activity of PLpro in vitro.These results reveal that parthenolide inhibits PLpro activity by allosteric regulation.
文献关键词:
作者姓名:
Zhihui Zou;Huizhuang Shan;Demeng Sun;Li Xia;Yulong Shi;Jiahui Wan;Aiwu Zhou;Yunzhao Wu;Hanzhang Xu;Hu Lei;Zhijian Xu;Yingli Wu
作者机构:
Hongqiao International Institute of Medicine,Shanghai Tongren Hospital/Faculty of Basic Medicine,Chemical Biology Division of Shanghai Universities E-Institutes,Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education,Chinese Academy of Medical Sciences Research Unit 2019RU043,Shanghai Jiao Tong University School of Medicine(SJTU-SM),Shanghai 200025,China;Laboratory Medicine,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,Guangdong 510000,China;Tsinghua-Peking Center for Life Sciences,Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology(Ministry of Education),Beijing Advanced Innovation Center for Structural Biology,Department of Chemistry,Tsinghua University,Beijing 100084,China;CAS Key Laboratory of Receptor Research,Drug Discovery and Design Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China
引用格式:
[1]Zhihui Zou;Huizhuang Shan;Demeng Sun;Li Xia;Yulong Shi;Jiahui Wan;Aiwu Zhou;Yunzhao Wu;Hanzhang Xu;Hu Lei;Zhijian Xu;Yingli Wu-.Parthenolide reveals an allosteric mode to inhibit the delSGylation activity of SARS-CoV-2 papain-like protease)[J].生物化学与生物物理学报(英文版),2022(08):1133-1139
A类:
delSGylation,germacrane
B类:
Parthenolide,reveals,allosteric,mode,activity,SARS,CoV,papain,like,protease,coronavirus,PLpro,severe,acute,respiratory,syndrome,is,responsible,polypeptide,cleavage,interferon,stimulated,gene,ISG15,which,enable,participate,replication,host,innate,immune,pathways,Therefore,considered,attractive,antiviral,drug,target,Here,we,show,that,parthenolide,sesquiterpene,lactone,has,inhibitory,covalently,binds,Cys,protein,but,not,catalytic,site,Mutation,reduces,Molecular,docking,studies,may,also,form,hydrogen,bonds,Lys,Thr,Gln,Furthermore,inhibits,deubiquitinating,vitro,These,results,by,regulation
AB值:
0.539227
相似文献
SARS-CoV-2 involvement in central nervous system tissue damage
Muhammad Ali Haidar;Zaynab Shakkour;Mohammad Amine Reslan;Nadine Al-Haj;Perla Chamoun;Karl Habashy;Hasan Kaafarani;Shima Shahjouei;Sarah H.Farran;Abdullah Shaito;Esber S.Saba;Bassam Badran;Mirna Sabra;Firas Kobeissy;Maya Bizri-Department of Biochemistry and Molecular Genetics,Faculty of Medicine,American University of Beirut,Beirut,Lebanon;Faculty of Health Sciences,University of Balamand,Beirut,Lebanon;Faculty of Medicine,University of Balamand,Koura,Lebanon;Faculty of Science,Lebanese University,Baabda,Lebanon;Program for Neurotrauma,Neuroproteomics&Biomarkers Research,Departments of Emergency Medicine,University of Florida,Gainesville,FL,USA;Department of Pathology and Laboratory Medicine,American University of Beirut Medical Center,Beirut,Lebanon;Biomedical Research Center,Qatar University,Doha,Qatar;Department of Experimental Pathology,Immunology and Microbiology,Faculty of Medicine,American University of Beirut,Beirut,Lebanon;Laboratory of Cancer Biology and Molecular Immunology,Faculty of Sciences I,Lebanese University,Hadath,Beirut,Lebanon;Faculty of Medicine,Lebanese University,Neuroscience Research Center(NRC),Beirut,Lebanon;Neuroscience Institute,Neurology Department,Geisinger Health System,PA,USA;Department of Psychiatry,American University of Beirut,Beirut,Lebanon
Potential medicinal plants involved in inhibiting 3CLpro activity:A practical alternate approach to combating COVID-19
Fan Yang;Xiao-lan Jiang;Akash Tariq;Sehrish Sadia;Zeeshan Ahmed;Jordi Sardans;Muhammad Aleem;Riaz Ullah;Rainer W.Bussmann-The Medical Center of General Practice,Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu 610041,Sichuan Province,China;Xinjiang Institute of Ecology and Geography,Chinese Academy of Sciences,Urumqi 830041,Xinjiang Uygur Autonomous Region,China;Department of Biological Sciences,University of Veterinary and Animal Sciences,Ravi Campus,Pattoki 55300,Pakistan;Consejo Superior de Investigaciones Científicas,Global Ecology Unit,Centre for Ecological Research and Forestry Applications-Consejo Superior de Investigaciones Cientificas-Universitat Autònoma de Barcelona,Bellaterra,Barcelona 08193,Catalonia,Spain;Centre for Ecological Research and Forestry Applications,Cerdanyola del Vallès 08193,Catalonia,Spain;Department of Pharmacognosy,College of Pharmacy,King Saud University,Riyadh 11451,Saudi Arabia;Department of Ethnobotany,Institute of Botany,Ilia State University,Tbilisi 0105,Georgia
SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation
Yichen Li;Shuaiyao Lu;Jinge Gu;Wencheng Xia;Shengnan Zhang;Shenqing Zhang;Yan Wang;Chong Zhang;Yunpeng Sun;Jian Lei;Cong Liu;Zhaoming Su;Juntao Yang;Xiaozhong Peng;Dan Li-Bio-X Institutes,Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders,Ministry of Education,Shanghai Jiao Tong University,Shanghai 200030,China;School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200030,China;National Kunming High-level Biosafety Primate Research Center,Institute of Medical Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Kunming 650031,China;State Key Laboratory of Medical Molecular Biology,Chinese Academy of Medical Sciences,School of Basic Medicine,Peking Union Medical College,Beijing 100005,China;Interdisciplinary Research Center on Biology and Chemistry,Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences,Shanghai 201210,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Biotherapy,Department of Geriatrics and National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University,Chengdu 610041,China;State Key Laboratory of Medical Molecular Biology,Department of Biochemistry and Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100005,China;Bio-X-Renji Hospital Research Center,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200240,China;Zhangjiang Institute for Advanced Study,Shanghai Jiao Tong University,Shanghai 200240,China
Targeting papain-like protease for broad-spectrum coronavirus inhibition
Shuofeng Yuan;Xiaopan Gao;Kaiming Tang;Jian-Piao Cai;Menglong Hu;Peng Luo;Lei Wen;Zi-Wei Ye;Cuiting Luo;Jessica Oi-Ling Tsang;Chris Chun-Yiu Chan;Yaoqiang Huang;Jianli Cao;Ronghui Liang;Zhenzhi Qin;Bo Qin;Feifei Yin;Hin Chu;Dong-Yan Jin;Ren Sun;Jasper Fuk-Woo Chan;Sheng Cui;Kwok-Yung Yuen-State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR,China;NHC Key Laboratory of Systems Biology of Pathogens,Institute of Pathogen Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;Department of Microbiology,Li Ka Shing,Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong SAR,China;School of Biomedical Sciences,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong SAR,China;Key Laboratory of Tropical Translational Medicine of Ministry of Education,Hainan Medical University,Haikou 571199,China;Academician Workstation of Hainan Province,Hainan Medical University,Haikou 571199,China;Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases,The University of Hong Kong,Pokfulam,Hong Kong Special Administrative Region,China;State Key Laboratory of Emerging Infectious Diseases,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong SAR,China;Guangzhou Laboratory,Guangzhou 510320,China;Department of Molecular and Medical Pharmacology,David Geffen School of Medicine,University of California Los Angeles,Los Angeles,CA,USA;Department of Clinical Microbiology and Infection Control,The University of Hong Kong-Shenzhen Hospital,Shenzhen 518053,China
Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins
Youwei Xu;Canrong Wu;Xiaodan Cao;Chunyin Gu;Heng Liu;Mengting Jiang;Xiaoxi Wang;Qingning Yuan;Kai Wu;Jia Liu;Deyi Wang;Xianqing He;Xueping Wang;Su-Jun Deng;H.Eric Xu;Wanchao Yin-The CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,China;Shanghai Jemincare Pharmaceuticals Co.,Ltd.,Shanghai,China;School of Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing,Jiangsu,China;The Shanghai Advanced Electron Microscope Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,China;University of Chinese Academy of Sciences,Beijing,China;School of Life Science and Technology,ShanghaiTech University,Shanghai,China;Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Guangdong,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
Yang Yi;Meng Zhang;Heng Xue;Rong Yu;Yang-Oujie Bao;Yi Kuang;Yue Chai;Wen Ma;Jing Wang;Xiaomeng Shi;Wenzhe Li;Wei Hong;Junhua Li;Elishiba Muturi;Hongping Wei;Joachim Wlodarz;Szczepan Roszak;Xue Qiao;Hang Yang;Min Ye-State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;CAS Key Laboratory of Special Pathogens and Biosafety,Center for Biosafety Mega-Science,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan 430071,China;University of Chinese Academy of Sciences,Beijing 100049,China;Faculty of Science and Technology,University of Silesia,Katowice 40-007,Poland;Department of Physical and Quantum Chemistry,Faculty of Chemistry,Wroclaw University of Science and Technology,Wroclaw 50-370,Poland
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang;Sui Fang;Yan Wu;Xi Cheng;Lei-ke Zhang;Xu-rui Shen;Shuang-qu Li;Jian-rong Xu;Wei-juan Shang;Zhao-bing Gao;Bing-qing Xia-CAS Key Laboratory of Receptor Research,Stake Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Pharmacology and Chemical Biology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Zhongshan Institute of Drug Discovery,Institution for Drug Discovery Innovation,Chinese Academy of Science,Zhongshan 528400,China
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Lin Wang;Yan Wu;Sheng Yao;Huan Ge;Ya Zhu;Kun Chen;Wen-zhang Chen;Yi Zhang;Wei Zhu;Hong-yang Wang;Yu Guo;Pei-xiang Ma;Peng-xuan Ren;Xiang-lei Zhang;Hui-qiong Li;Mohammad A.Ali;Wen-qing Xu;Hua-liang Jiang;Lei-ke Zhang;Li-li Zhu;Yang Ye;Wei-juan Shang;Fang Bai-Shanghai Institute for Advanced Immunochemical Studies,ShanghaiTech University,Shanghai 201210,China;School of Life Science and Technology,ShanghaiTech University,Shanghai 201210,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430064,China;Department of Natural Products Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Bioreactor Engineering,Shanghai Key Laboratory of New Drug Design,School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China;CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;College of Pharmacy and State Key Laboratory of Medicinal Chemical Biology,Nankai University,Tianjin 300071,China;Department of Botany and Microbiology,College of Science,King Saud University,Riyadh,Saudi Arabia
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。